On-Demand Webinar

CGM, BGM, or Both? How to Choose the Right Glucose Monitoring Approach for Your Clinical Trial

As glucose monitoring becomes more central to clinical trial endpoints and patient safety, selecting the right blood glucose monitoring device isn’t just a data decision. It’s a strategic choice that affects cost, compliance, and, ultimately, the participants.

In this on-demand webinar, YPrime experts break down the real-world tradeoffs of CGM vs BGM across a range of therapeutic areas. You’ll explore how these tools shape patient experience, data integrity, and trial execution—especially when paired with eCOA and connected device strategies.

Whether your study focuses on GLP-1, cardiometabolic, PCOS, NASH, or other emerging indications, this session offers practical guidance to help you align your glucose monitoring approach in clinical trials with your protocol and population needs.

Woman in workout clothes checking her phone post-exercise, representing patient use of CGM or BGM devices in clinical trials

What You’ll Learn

When CGM is Worth It, and When It’s Not — use case-driven frameworks to determine when real-time monitoring is essential versus when retrospective BGM provides a better cost-benefit balance.

Pitfalls to Avoid with BGM/ CGM — evaluating eCOA integrations while considering patient experience and compliance.

Management of Data — and how integrated systems allow for the transmission of real-time data to flow seamlessly from connected devices to the sponsor’s desktop.

Watch the On-Demand Webinar

Fill out the form to access the full session and gain expert insights on glucose monitoring and eCOA integration in today’s most complex trials.

Want to dive deeper into device strategy? Download our eCOA + Connected Devices Playbook for practical guidance on integrating wearables and glucose monitoring into your studies.